Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report

Narumi, Y; Yoshida, R; Minami, Y; Yamamoto, Y; Takeguchi, S; Kano, K; Takahashi, K; Saito, T; Sawada, J; Terui, H; Katayama, T; Sasaki, T; Ohsaki, Y

Yoshida, R (reprint author), Asahikawa Med Univ, Resp Ctr, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.

BMC CANCER, 2018; 18 ():

Abstract

Background: Immune checkpoint blockade is developed as standard treatment for non-small cell lung cancer. However immune-related adverse events (irAE)......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索